Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

260.92
+3.801.48%
Volume:599.24K
Turnover:156.94M
Market Cap:461.15B
PE:73.71
High:264.65
Open:263.71
Low:260.65
Close:257.12
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.25
T/O Rate:0.03%
Dividend:6.83
Dividend Rate:2.62%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-77.70
PE(LYR):110.56

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Aug 01

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

TIPRANKS
·
Aug 01

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

TIPRANKS
·
Aug 01

AbbVie Publishes Pipeline Presentation Highlighting July 2026 R&D Program Updates

Reuters
·
Jul 31

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

Benzinga Earnings
·
Jul 31

Movement Alert|AbbVie Falls 3.04% in Regular Trading, Q2 Beat Overshadowed by Full-Year EPS Guidance Cut on Acquisition Dilution

Market Focus
·
Jul 31

AbbVie says ‘quite pleased’ with Skyrizi momentum

TIPRANKS
·
Jul 31

AbbVie Has 2Q Beat Helped by Skyrizi and Rinvoq

Dow Jones
·
Jul 31

Abbvie Shares Down 2.2% After Co Trims 2026 Profit Forecast

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says NOW Expect Total Annual Net Revenue of Approximately $67.6 Billion, Increase of $300 Million Versus Previous Forecast - Conf Call

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says in Third Quarter it Expects Adjusted Profit Per Share Between $3.84 and $3.88 - Conf Call

THOMSON REUTERS
·
Jul 31

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.

Dow Jones
·
Jul 31

AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps

Dow Jones
·
Jul 31

AbbVie Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 31

AbbVie Falls After Trimming 2026 Profit Forecast

Reuters
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Movement Alert|AbbVie Falls 4.29% in Pre-Market Trading, Q2 Earnings Beat Expectations but Acquisition Dilution Weighs on Full-Year Guidance

Market Focus
·
Jul 31

AbbVie Q2 2026 earnings: Immunology and neuroscience drive 10.2% revenue growth

TradingKey
·
Jul 31

Abbvie Shares Down 3.6% Premarket After Co Cuts 2026 Profit Forecast on Apogee Buy

THOMSON REUTERS
·
Jul 31

GUIDANCE: (ABBV) AbbVie Expects 2026 Adjusted EPS Range $13.87 - $14.07, vs. FactSet Est of $14.06

MT Newswires Live
·
Jul 31